In this article, we will discuss the 12 Biggest Genomics Companies In The World.
Keep Reading →
October 29 - Lists, News - Comments
This article discusses the top 10 healthcare stock picks of billionaire Larry Robbins’ hedge fund Glenview Capital Management.
Keep Reading →
September 26 - Hedge Fund Analysis, Hedge Funds, News - Comments
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Keep Reading →
July 28 - Hedge Funds, News - Comments
In this article, we will take a look at the top 10 investments of Balaji Srinivasan and see his thoughts on China's ability to undermine crypto.
Keep Reading →
May 20 - Hedge Funds, News - Comments
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
October 5 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
July 5 - Hedge Funds, News - Comments
We hate to say this but, we told you so.
Keep Reading →
April 7 - Hedge Funds, News - Comments
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 10 percentage points since the end of the third quarter of 2018 as investors first worried over the possible...
Keep Reading →
December 19 - Hedge Funds, News - Comments
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock.
Keep Reading →
October 21 - Hedge Funds, News - Comments
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Keep Reading →
July 5 - Hedge Funds, News - Comments
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Keep Reading →
April 29 - Hedge Funds, News - Comments
Is Myriad Genetics, Inc.
Keep Reading →
December 14 - Hedge Funds, News - Comments
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
Keep Reading →
December 1 - Hedge Funds, News - Comments
SLS Management is a New York-based hedge fund that was founded by Scott Lawrence Swid.
Keep Reading →
November 18 - Hedge Funds, News - Comments
Markets are trading on an optimistic note as all the major indices are in green zone.
Keep Reading →
October 10 - Market Movers, News - Comments
While crude prices are now at a monthly high and the S&P 500 is above 2,100, some stocks have been left behind. Among the stocks deep in the red today are Rambus Inc.
Keep Reading →
April 19 - Market Movers, News - Comments
The third quarter was a rough one for most investors, as fears of an interest rate hike in the U.S, a weakening economy in China, and a stagnant Europe, weighed heavily on the...
Keep Reading →
November 27 - Hedge Funds, News - Comments
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD.
Keep Reading →
May 27 - Hedge Funds, News - Comments
To many market players, hedge funds are viewed as delayed, old investment vehicles of a period lost to current times.
Keep Reading →
September 17 - News - Comments
In the 21st century investor’s toolkit, there are plenty of gauges shareholders can use to track the equity markets.
Keep Reading →
August 28 - News - Comments
On a day-to-day basis, there are countless analyst calls – some of which are good and others that are bad – and in this piece, I am looking at three in particular to determine...
Keep Reading →
June 28 - News - Comments
According to most shareholders, hedge funds are assumed to be slow, outdated investment vehicles of the past.
Keep Reading →
June 19 - News - Comments
It’s not easy being a biotech company.
Keep Reading →
June 18 - News - Comments
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
June 14 - News - Comments
Forrester Research, Inc. (NASDAQ:FORR) was in 11 hedge funds' portfolio at the end of March. FORR has seen a decrease in hedge fund interest lately.
Keep Reading →
June 10 - News - Comments
On June 30, the Supreme Court is going to make a decision on a case filed by the Association for Molecular Biology on human genome patentability against Myriad Genetics, Inc...
Keep Reading →
June 5 - News - Comments
Myriad Genetics, Inc. (NASDAQ:MYGN) was in 19 hedge funds' portfolio at the end of March. MYGN has experienced a decrease in enthusiasm from smart money in recent months.
Keep Reading →
May 30 - News - Comments
I admit to not being a big fan of many of her movies -- possibly the only man on the planet who will admit so -- but there's little denying that movie sensation Angelina Jolie...
Keep Reading →
May 16 - News - Comments
Sony Corporation (ADR) (NYSE:SNE) – Big prints in Sony Corporation (ADR) (NYSE:SNE) call and put options this morning pushed the consumer electronics maker onto our ‘hot...
Keep Reading →
May 14 - News - Comments
Sony Corporation (ADR) (NYSE:SNE) – Big prints in Sony Corporation (ADR) (NYSE:SNE) call and put options this morning pushed the consumer electronics maker onto our ‘hot...
Keep Reading →
May 13 - News - Comments
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc.
Keep Reading →
April 15 - News - Comments
To the average investor, there are a multitude of methods investors can use to analyze stocks.
Keep Reading →
March 22 - News - Comments
Monday was a somewhat slow day in terms of companies reporting earnings; however like all days during earnings season, opportunity still presented itself.
Keep Reading →
March 5 - News - Comments
The market has been less than thrilled about an upcoming Supreme Court decision on the legality of the best-selling analytical test of Myriad Genetics, Inc. (NASDAQ:MYGN) .
Keep Reading →
March 5 - News - Comments